Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review

INTRODUCTION: Aliskiren is a newly developed medicine. As one of the effective renin–angiotensin–aldosterone system inhibitors, its role in lowering blood pressure has been recognised. However, its safety and tolerability still remain controversial. The aim of the paper is to systematically summaris...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qiyuan, Shen, Jiantong, Lu, Jingya, Li, Fan, Jiang, Qi, Wang, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045264/
https://www.ncbi.nlm.nih.gov/pubmed/31969367
http://dx.doi.org/10.1136/bmjopen-2019-033448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045264/
https://www.ncbi.nlm.nih.gov/pubmed/31969367
http://dx.doi.org/10.1136/bmjopen-2019-033448

Ejemplares similares